Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1981 1
1983 1
1986 1
1988 2
1991 5
1992 5
1993 1
1994 1
1995 1
1997 4
1998 6
1999 3
2000 1
2001 2
2002 3
2003 2
2004 3
2005 3
2006 10
2007 6
2008 4
2009 4
2010 4
2011 2
2012 3
2013 3
2014 3
2015 7
2016 9
2017 12
2018 8
2019 14
2020 14
2021 16
2022 11
2023 4
2024 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

168 results

Results by year

Filters applied: . Clear all
Page 1
Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trial.
Danese S, Vermeire S, D'Haens G, Panés J, Dignass A, Magro F, Nazar M, Le Bars M, Lahaye M, Ni L, Bravata I, Lavie F, Daperno M, Lukáš M, Armuzzi A, Löwenberg M, Gaya DR, Peyrin-Biroulet L; STARDUST study group. Danese S, et al. Lancet Gastroenterol Hepatol. 2022 Apr;7(4):294-306. doi: 10.1016/S2468-1253(21)00474-X. Epub 2022 Feb 1. Lancet Gastroenterol Hepatol. 2022. PMID: 35120656 Clinical Trial.
Reply.
Espi A, Herreros B, Mínguez M. Espi A, et al. Among authors: minguez m. Dis Colon Rectum. 2022 May 1;65(5):e340. doi: 10.1097/DCR.0000000000002435. Dis Colon Rectum. 2022. PMID: 35185136 No abstract available.
Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study.
Chaparro M, Garre A, Núñez Ortiz A, Diz-Lois Palomares MT, Rodríguez C, Riestra S, Vela M, Benítez JM, Fernández Salgado E, Sánchez Rodríguez E, Hernández V, Ferreiro-Iglesias R, Ponferrada Díaz Á, Barrio J, Huguet JM, Sicilia B, Martín-Arranz MD, Calvet X, Ginard D, Alonso-Abreu I, Fernández-Salazar L, Varela Trastoy P, Rivero M, Vera-Mendoza I, Vega P, Navarro P, Sierra M, Cabriada JL, Aguas M, Vicente R, Navarro-Llavat M, Echarri A, Gomollón F, Guerra Del Río E, Piñero C, Casanova MJ, Spicakova K, Ortiz de Zarate J, Torrella Cortés E, Gutiérrez A, Alonso-Galán H, Hernández-Martínez Á, Marrero JM, Lorente Poyatos R, Calafat M, Martí Romero L, Robledo P, Bosch O, Jiménez N, Esteve Comas M, Duque JM, Fuentes Coronel AM, Josefa Sampedro M, Sesé Abizanda E, Herreros Martínez B, Pozzati L, Fernández Rosáenz H, Crespo Suarez B, López Serrano P, Lucendo AJ, Muñoz Vicente M, Bermejo F, Ramírez Palanca JJ, Menacho M, Carmona A, Camargo R, Torra Alsina S, Maroto N, Nerín de la Puerta J, Castro E, Marín-Jiménez I, Botella B, Sapiña A, Cruz N, Forcelledo JLF, Bouhmidi A, Castaño-Milla C, Opio V, Nicolás I, Kutz M, Abraldes Bechiarelli A, Gordillo J, Ber Y, Torres Domínguez Y, Novella Durán … See abstract for full author list ➔ Chaparro M, et al. J Clin Med. 2021 Jun 29;10(13):2885. doi: 10.3390/jcm10132885. J Clin Med. 2021. PMID: 34209680 Free PMC article.
I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease.
Peyrin-Biroulet L, Rahier JF, Kirchgesner J, Abitbol V, Shaji S, Armuzzi A, Karmiris K, Gisbert JP, Bossuyt P, Helwig U, Burisch J, Yanai H, Doherty GA, Magro F, Molnar T, Löwenberg M, Halfvarson J, Zagorowicz E, Rousseau H, Baumann C, Baert F, Beaugerie L; I-CARE Collaborator Group. Peyrin-Biroulet L, et al. Clin Gastroenterol Hepatol. 2023 Mar;21(3):771-788.e10. doi: 10.1016/j.cgh.2022.09.018. Epub 2022 Sep 22. Clin Gastroenterol Hepatol. 2023. PMID: 36152897 Free article.
Caustic Ingestion: A Risk-Based Algorithm.
Tosca J, Sánchez A, Sanahuja A, Villagrasa R, Poyatos P, Mas P, Pascual I, Lluch P, Herreros B, Peña A, Sánchiz V, Mínguez M. Tosca J, et al. Among authors: minguez m. Am J Gastroenterol. 2022 Oct 1;117(10):1593-1604. doi: 10.14309/ajg.0000000000001953. Epub 2022 Aug 18. Am J Gastroenterol. 2022. PMID: 36194047
[Infective esophagitis].
Mínguez M, Mora F, Peña A, Benages A. Mínguez M, et al. An Med Interna. 1994 Aug;11(8):404-7. An Med Interna. 1994. PMID: 7772691 Review. Spanish. No abstract available.
Chronic Anal Fissure.
Minguez M, Herreros B, Benages A. Minguez M, et al. Curr Treat Options Gastroenterol. 2003 Jun;6(3):257-262. doi: 10.1007/s11938-003-0007-8. Curr Treat Options Gastroenterol. 2003. PMID: 12744825
Pathogenesis of Crohn's disease: Bug or no bug.
Bosca-Watts MM, Tosca J, Anton R, Mora M, Minguez M, Mora F. Bosca-Watts MM, et al. Among authors: minguez m. World J Gastrointest Pathophysiol. 2015 Feb 15;6(1):1-12. doi: 10.4291/wjgp.v6.i1.1. World J Gastrointest Pathophysiol. 2015. PMID: 25685606 Free PMC article. Review.
[Treatment of chronic anal fissure].
García-Granero E, Muñoz-Forner E, Mínguez M, Ballester C, García-Botello S, Lledó S. García-Granero E, et al. Among authors: minguez m. Cir Esp. 2005 Dec;78 Suppl 3:24-7. doi: 10.1016/s0009-739x(05)74640-6. Cir Esp. 2005. PMID: 16478612 Free article. Review. Spanish.
168 results